National Cancer Institute NCI CAMNews Spring 2008 Vol.3- Issue 1

First Page		Document Content
Date: 2009-10-07 14:43:06 Carcinogenesis Office of Cancer Complementary and Alternative Medicine Cancer stem cell Cancer research Prostate cancer Cancer Resveratrol Management of cancer Medicine Oncology Cancer organizations		National Cancer Institute NCI CAMNews Spring 2008 Vol.3- Issue 1 Add to Reading List Source URL: cam.cancer.gov Download Document from Source Website File Size: 392,12 KB Share Document on Facebook

	Laboratory Investigation, 970–982 & 2013 USCAP, Inc All rights reserved $32.00 PATHOBIOLOGY IN FOCUS Patient-derived xenografts, the cancer stem cell DocID: 1uW4K - View Document
	24th NSW Stem Cell Network Workshop Stem Cells and Cancer Darlington Centre City Rd, Sydney Wednesday, April 6th, 2016 DocID: 1uNr2 - View Document
	Guideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Car DocID: 1tWUj - View Document
	A Phase 1b Study of the Anti-Cancer Stem Cell Agent Demcizumab, Pemetrexed and Carboplatin in Patients with Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1 Stagg R, DocID: 1t7Mt - View Document
	Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in DocID: 1t4Bh - View Document